This DEFA14A likely accompanies a definitive proxy statement (DEF14A) or preliminary materials related to an activist/dissident proxy contest. The cross-filing amplifiers strongly suggest an ongoing campaign with potential board changes or shareholder proposals. Traders should locate the related DEF14A or preliminary proxy for specific vote items and activist demands.
Price Chart
Executive Summary
PDS Biotechnology Corp filed a DEFA14A, which is additional definitive proxy soliciting material. The document body is almost entirely comprised of encoded/compressed graphical data and contains no readable text describing specific proposals, shareholder votes, or activist demands. With no substantive content available, the filing appears to be a routine cover-page-only submission of graphic exhibits related to a proxy solicitation.
Key Facts
- Filed as DEFA14A (additional definitive proxy soliciting materials) on 2026-06-26
- Filer is PDS Biotechnology Corp, a pharmaceutical preparations company
- Document text contains only EDGAR headers, a Schedule 14A cover page, and two large binary graphic files (JPG images)
- No textual details on meeting agenda, proposals, or activist demands were found in the filing
- Evidence of an ongoing dissident proxy campaign indicated by cross-filing actuarial verdicts, which universally amplified the combination of 'dissident-proxy-activist-context' with preliminary, executive change, and DEF14A contexts
Financial Impact
No financial figures disclosed in the filing
Risk Factors
- No substantive content in this filing limits actionable analysis
- Activists/dissidents may be seeking board seats or strategic changes that could affect company direction
- Proxy fights in small-cap biotechs (market cap ~$49M) can lead to significant stock volatility
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001140361-26-026570 |
| Document: 0001140361-26-026570-index-headers.html | 0001140361-26-026570 |
| Document: 0001140361-26-026570-index.html | 0001140361-26-026570 |
| Document: 0001140361-26-026570.txt | 0001140361-26-026570 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 27d ago | 8-K | $0.3000 $0.5853 | ▼ −95.10% | ▼ −96.22% | $0.7366 (−145.53%) |
Aug 19, 2026 6w ago | 8-K | $0.2089 $0.2179 | ▲ +4.31% | ▲ +3.19% | $0.7366 (+252.61%) |
Aug 13, 2026 7w ago | 8-K | $0.2332 $0.2089 | ▲ +10.42% | ▲ +8.46% | $0.7366 (−215.87%) |
Aug 11, 2026 7w ago | 8-K | $0.2570 $0.2080 | ▲ +19.07% | ▲ +18.66% | $0.7366 (−186.61%) |
Jul 22, 2026 10w ago | EFFECT | $0.7155 $0.6696 | ▲ +6.42% | ▲ +4.01% | $0.7366 (−2.95%) |
Jun 26, 2026 13w ago | DEFA14A | $0.8991 $0.8461 | ▼ −5.89% | ▼ −7.28% | $0.7366 (−18.07%) |
Jun 15, 2026 15w ago | 8-K | $0.9600 $0.9120 | ▲ +5.00% | ▲ +2.77% | $0.7366 (+23.27%) |
Jun 15, 2026 15w ago | 8-K | $1.02 $0.9412 | ▼ −7.73% | ▼ −6.34% | $0.7366 (−27.78%) |
Jun 2, 2026 17w ago | 8-K | $1.16 $1.03 | ▼ −11.21% | ▼ −8.24% | $0.7366 (−36.50%) |
May 13, 2026 20w ago | Press Release | $1.33 $1.00 | ▼ −24.81% | ▼ −23.65% | $0.7366 (−44.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access